Lactoferrin inhibits the binding of lipopolysaccharides to L-selectin and subsequent production of reactive oxygen species by neutrophils

FEBS Lett. 2000 Mar 3;469(1):5-8. doi: 10.1016/s0014-5793(00)01243-6.

Abstract

The activation of leukocytes by lipopolysaccharides (LPS), resulting in the oxidative burst, contributes to the pathogenesis of septic shock. The binding of LPS to L-selectin, which was reported as a serum-independent LPS receptor on neutrophils, induces the production of oxygen free radicals. Human lactoferrin (hLf), an anti-inflammatory glycoprotein released from neutrophil granules during infection, binds to LPS. In this study, we investigated the capacity of hLf to inhibit the L-selectin-mediated activation of neutrophils. Our experiments revealed that hLf prevents the binding of LPS to L-selectin in a concentration-dependent manner. Inhibition was maximum (87.7+/-0.5%) at a concentration of 50 microg/ml of hLf. Furthermore, hLf inhibited up to 55.4+/-0.5% of the intracellular hydrogen peroxide production induced by LPS in neutrophils. These findings suggest that the anti-inflammatory properties of hLf are due, at least in part, to their ability to prevent the binding of LPS to neutrophil L-selectin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Escherichia coli
  • Flow Cytometry
  • Fluorescent Dyes
  • Humans
  • Hydrogen Peroxide / metabolism
  • Inflammation / metabolism
  • L-Selectin / metabolism*
  • Lactoferrin / pharmacology*
  • Lipopolysaccharides / metabolism*
  • Neutrophils / drug effects
  • Neutrophils / metabolism*
  • Protein Binding
  • Reactive Oxygen Species / metabolism*

Substances

  • Fluorescent Dyes
  • Lipopolysaccharides
  • Reactive Oxygen Species
  • L-Selectin
  • Hydrogen Peroxide
  • Lactoferrin